MA43096A - BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES - Google Patents

BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES

Info

Publication number
MA43096A
MA43096A MA043096A MA43096A MA43096A MA 43096 A MA43096 A MA 43096A MA 043096 A MA043096 A MA 043096A MA 43096 A MA43096 A MA 43096A MA 43096 A MA43096 A MA 43096A
Authority
MA
Morocco
Prior art keywords
cgrp
antibodies
bispecific
bispecific anti
Prior art date
Application number
MA043096A
Other languages
French (fr)
Inventor
Barrett Allan
Catherine Brautigam Beidler
Robert Jan Benschop
Rohn Lee Millican Jr
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to MA043096A priority Critical patent/MA43096A/en
Publication of MA43096A publication Critical patent/MA43096A/en

Links

MA043096A 2015-10-30 2015-10-30 BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES MA43096A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MA043096A MA43096A (en) 2015-10-30 2015-10-30 BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MA043096A MA43096A (en) 2015-10-30 2015-10-30 BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES

Publications (1)

Publication Number Publication Date
MA43096A true MA43096A (en) 2021-04-28

Family

ID=77522873

Family Applications (1)

Application Number Title Priority Date Filing Date
MA043096A MA43096A (en) 2015-10-30 2015-10-30 BISPECIFIC ANTI-CGRP / ANTI-IL-23 ANTIBODIES AND THEIR USES

Country Status (1)

Country Link
MA (1) MA43096A (en)

Similar Documents

Publication Publication Date Title
FR24C1023I2 (en) THERAPEUTIC ANTIBODIES AND THEIR USES
MA42935A (en) OPTIMIZED ANTI-CD3 BISPECIFIC ANTIBODIES AND THEIR USES
MA49537A (en) ANTI-LAG3 ANTIBODIES AND THEIR USES
EP3625263A4 (en) ANTI-GALECTIN-9 ANTIBODIES AND THEIR USES
EP3328895A4 (en) ANTI-PD-L1 ANTIBODIES AND USES THEREOF
EP3426686A4 (en) HUMANIZED ANTI-PACAP ANTIBODIES AND USES THEREOF
MA45235A (en) ANTI-C5 ANTIBODIES AND THEIR USES
MA49687A (en) ANTI-CTLA-4 ANTIBODIES AND THEIR USES
EP3504243A4 (en) ANTI-TIM-3 ANTIBODIES AND USES THEREOF
MA46704A (en) ANTI-PYROGLUTAMATE- AMYLOID-BETA ANTIBODIES AND THEIR USES
MA47789A (en) ANTI-PHF-TAU ANTIBODIES AND THEIR USES
EP3383916A4 (en) ANTI-CD73 ANTIBODIES AND USES THEREOF
EP3283517A4 (en) ANTI-PACAP ANTIBODIES AND USES THEREOF
EP3389702A4 (en) ANTI-LAG-3 ANTIBODIES AND USES THEREOF
EP3356416A4 (en) ANTI-PD-1 ANTIBODIES AND USES THEREOF
MA46708A (en) ANTI-PD1 ANTIBODIES AND THEIR USES
MA53184A (en) ANTI-OX40 ANTIBODIES AND THEIR USES
EP3383904A4 (en) CTLA-4 ANTIBODIES AND USES THEREOF
EP2970505A4 (en) BISPECIFIC ANTIBODIES AND USES THEREOF
EP2981286A4 (en) ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF
EP3377102C0 (en) ANTI-PD-1 ANTIBODIES AND THEIR THERAPEUTIC USES
MA49886A (en) ANTI-PAR2 ANTIBODIES AND THEIR USES
MA45125A (en) ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND THEIR USES
EP3400243A4 (en) ANTI-PD-L1 ANTIBODIES AND USES THEREOF
EP3362482A4 (en) ANTI-PCSK9 ANTIBODIES AND USES THEREOF